In the years following its discovery, the 67LR was reported to be overexpressed in neoplastic cells, contributing to aggressiveness and poor prognosis in a wide variety of cancers [15], including CRC in which the 67LR expression has been correlated with disease progression [16,17,18,19]. This evidence concerns the gene RPSA and cancer.